ANTX•businesswire•
AN2 Therapeutics to Participate in Fireside Chat at Evercore HealthCONx Conference
Summary
MENLO PARK, Calif.--(BUSINESS WIRE)--AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform, today announced that Eric Easom, Co-Founder, Chairman, President and CEO, will participate in a fireside chat at the 8th Annual Evercore HealthCONx Conference being held from December 2-4, 2025. Details of the event are as follows: Eric Easom, Co-Founder, Chairman, President and
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on November 6, 2025 by businesswire